Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 19, 2026
- Accession no.
- 0001636178-26-000019
- Filed
- May 19, 2026
- Trade date
- May 18, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.67M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | MOption exerciseAcquired | +2,500 | $135.42 | +$338,550 | 21,376 | Direct | |
| May 18, 2026 | Common Stock | MOption exerciseAcquired | +7,500 | $117.76 | +$883,200 | 28,876 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −200 | $562.91F2 | −$112,582 | 28,676 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −422 | $564.30F3 | −$238,134.6 | 28,254 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −2,131 | $565.44F4 | −$1,204,952.64 | 26,123 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −1,796 | $566.39F5 | −$1,017,236.44 | 24,327 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −2,785 | $568.48F6 | −$1,583,216.8 | 21,542 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −1,304 | $568.43F7 | −$741,232.72 | 20,238 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −1,322 | $569.56F8 | −$752,958.32 | 18,916 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −40 | $570.18 | −$22,807.2 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct | |
| May 18, 2026 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 80,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $562.56 to $563.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $563.93 to $564.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $564.93 to $565.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $565.96 to $566.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $567.01 to $567.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $568.01 to $569.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $569.17 to $570.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.